
Sarah provides strategic FDA regulatory and compliance counsel to life sciences clients on a variety of matters, including pharmacovigilance, Good Clinical Practice and clinical trials, medical communications and health care economic information, advertising and promotion, patient support programs, and ClinicalTrials.gov registration and reporting.
证书
奖项和认可
- Named to list of Top 40 Under 40 in Texas by The National Black Lawyers (2021- 2023)
- Selected to participate in the Leadership Council on Legal Diversity Pathfinders program (2021)
- Selected to Thomson Reuters’ “Super Lawyers - Rising Stars” List (2023)
Notable quotes
- 19 January 2023 "Diversity in Clinical Trials at FDA Gets a Boost From New Law," Bloomberg Law